<scp>HER2</scp> overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the <scp>QUASAR</scp>, <scp>FOCUS</scp> and <scp>PICCOLO</scp> colorectal cancer trialsSusan D. Richman, Philip Quirke, Philip Chambers et al.|The Journal of Pathology|2015Cited by 238